Opexa Therapeutics

Opexa Therapeutics ( OPXA) is engaged in developing personalized cellular therapies with the potential to treat major illnesses, including multiple sclerosis. This stock is trading up 4.3% to $1.88 in recent trading.

Today's Range: $1.79-$1.91
52-Week Range: $1.07-$5.19
Volume: 244,000
Three-Month Average Volume: 387,623

From a technical perspective, OPXA is trending higher here and just starting to take out its 50-day moving average at $1.86 with decent upside volume. This move is quickly pushing shares of OPXA within range of triggering a major breakout trade. That trade will hit if OPXA manages to take out $1.92 to its 200-day at $2.05 and then once it clears more resistance at $2.25 with high volume. At last check, OPXA has hit an intraday high of $1.91 and volume is above 100,000 shares below its three-month average action of 387,623 shares.

Traders should now look for long-biased trades in OPXA as long as it's trending above today's low of $1.79 and then once it sustains a move or close above those breakout levels with volume that hits near or above 387,623 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.82 to $3.25. Any high-volume move above $3.25 could then send this stock past $4.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Madison, Wis.

RELATED LINKS:



Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Madison, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.

If you liked this article you might like

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Higher

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Advancing The Drugs Industry

3 Drugs Stocks Pushing The Industry Higher